TerminatedNot Applicable

Transcranial Direct Current Stimulation for Pain Treatment in Gulf War Illness.

Stopped: Funding finished

United States9 participantsStarted 2018-03-12

Plain-language summary

The goal of this study is to investigate long-term modulation of pain pathways leading to a suppression of pain symptoms in Gulf War Illness patients by applying transcranial direct current stimulation.

Who can participate

Age range45 Years – 78 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Male and female US military veterans serving during the 1990-1991 Gulf War.
✓. Men and women between the ages of 18 and 50 years old during service in the Gulf War (born between 1940 and 1973).
✓. English speakers.

Exclusion criteria

✕. Non-English speakers.
✕. History of a neurological disorder, including dementia of any type, moderate to severe traumatic brain injury (TBI), brain tumors, present or past drug abuse, stroke, blood vessel abnormalities in the brain, Parkinson's disease, Huntington's disease, or multiple sclerosis. Traumatic brain injury will be screened by history.
✕. No subjects will be enrolled who are cognitively or clinically incompetent to give informed consent.
✕. Subjects cannot be taking medications that include: amphetamines, L-dopa, carbamazepine, sulpiride, pergolide, lorazepam, rivastigmine, dextromethorphan, D-cycloserine, flunarizine, ropinirole,or citalopram.
✕. Subjects with cardiac pacemakers, implanted medication pumps of any sort, or a history of bad heart disease, a history of seizures and/or family members with a history of seizures, and/or the presence of any metal objects in or near the head which cannot be safely removed for the duration of this study.

What they're measuring

Pain Symptom Changes Will be Measured by a Visual Analogue Scale for Pain .

Timeframe: Before tDCS stimulation (baseline), immediately after (immediate-post) tDCS intervention measurements and 1 week, 4 weeks, 12 weeks and 24 weeks after the last tDCS session.

Trial details

NCT IDNCT03547869

SponsorThe University of Texas at Dallas

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-01-25

Results submitted2023-02-14

View on ClinicalTrials.gov More Gulf War Syndrome trials